Global Personalized Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Personalized Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 108

Published Date: 12 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Personalized Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease
The Global Info Research report includes an overview of the development of the Personalized Cell Therapy industry chain, the market status of Cardiovascular Diseases (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell), Neurological Disorders (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Personalized Cell Therapy.

Regionally, the report analyzes the Personalized Cell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Personalized Cell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Personalized Cell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Personalized Cell Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hematopoietic Stem Cell, Skeletal Muscle Stem Cell).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Personalized Cell Therapy market.

Regional Analysis: The report involves examining the Personalized Cell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Personalized Cell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Personalized Cell Therapy:
Company Analysis: Report covers individual Personalized Cell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Personalized Cell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular Diseases, Neurological Disorders).

Technology Analysis: Report covers specific technologies relevant to Personalized Cell Therapy. It assesses the current state, advancements, and potential future developments in Personalized Cell Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Personalized Cell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Personalized Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
By Cell Type
Hematopoietic Stem Cell
Skeletal Muscle Stem Cell
Mesenchymal Stem Cells
Lymphocytes
Others
By Technique
Platelet Transfusions
Bone Marrow Transplantation
Packed Red Cell Transfusions
Organ Transplantation

Market segment by Application
Cardiovascular Diseases
Neurological Disorders
Inflammatory Diseases
Diabetes
Cancer
Others

Market segment by players, this report covers
Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics,Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Cell Therapy, with revenue, gross margin and global market share of Personalized Cell Therapy from 2019 to 2024.
Chapter 3, the Personalized Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Personalized Cell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Cell Therapy.
Chapter 13, to describe Personalized Cell Therapy research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Personalized Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Cell Therapy by Type
1.3.1 Overview: Global Personalized Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Personalized Cell Therapy Consumption Value Market Share by Type in 2023
1.3.3 Hematopoietic Stem Cell
1.3.4 Skeletal Muscle Stem Cell
1.3.5 Mesenchymal Stem Cells
1.3.6 Lymphocytes
1.3.7 Others
1.4 Global Personalized Cell Therapy Market by Application
1.4.1 Overview: Global Personalized Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cardiovascular Diseases
1.4.3 Neurological Disorders
1.4.4 Inflammatory Diseases
1.4.5 Diabetes
1.4.6 Cancer
1.4.7 Others
1.5 Global Personalized Cell Therapy Market Size & Forecast
1.6 Global Personalized Cell Therapy Market Size and Forecast by Region
1.6.1 Global Personalized Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Personalized Cell Therapy Market Size by Region, (2019-2030)
1.6.3 North America Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Personalized Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Personalized Cell Therapy Product and Solutions
2.1.4 Novartis AG Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Vericel Corporation
2.2.1 Vericel Corporation Details
2.2.2 Vericel Corporation Major Business
2.2.3 Vericel Corporation Personalized Cell Therapy Product and Solutions
2.2.4 Vericel Corporation Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Vericel Corporation Recent Developments and Future Plans
2.3 Bellicum Pharmaceuticals
2.3.1 Bellicum Pharmaceuticals Details
2.3.2 Bellicum Pharmaceuticals Major Business
2.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Product and Solutions
2.3.4 Bellicum Pharmaceuticals Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bellicum Pharmaceuticals Recent Developments and Future Plans
2.4 MolMed SpA
2.4.1 MolMed SpA Details
2.4.2 MolMed SpA Major Business
2.4.3 MolMed SpA Personalized Cell Therapy Product and Solutions
2.4.4 MolMed SpA Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MolMed SpA Recent Developments and Future Plans
2.5 Cytori Therapeutics Inc
2.5.1 Cytori Therapeutics Inc Details
2.5.2 Cytori Therapeutics Inc Major Business
2.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Product and Solutions
2.5.4 Cytori Therapeutics Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cytori Therapeutics Inc Recent Developments and Future Plans
2.6 Gilead Sciences, Inc
2.6.1 Gilead Sciences, Inc Details
2.6.2 Gilead Sciences, Inc Major Business
2.6.3 Gilead Sciences, Inc Personalized Cell Therapy Product and Solutions
2.6.4 Gilead Sciences, Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business
2.7.3 Celgene Corporation Personalized Cell Therapy Product and Solutions
2.7.4 Celgene Corporation Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Celgene Corporation Recent Developments and Future Plans
2.8 Bluebird Bio
2.8.1 Bluebird Bio Details
2.8.2 Bluebird Bio Major Business
2.8.3 Bluebird Bio Personalized Cell Therapy Product and Solutions
2.8.4 Bluebird Bio Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bluebird Bio Recent Developments and Future Plans
2.9 Aurora Biopharma Inc
2.9.1 Aurora Biopharma Inc Details
2.9.2 Aurora Biopharma Inc Major Business
2.9.3 Aurora Biopharma Inc Personalized Cell Therapy Product and Solutions
2.9.4 Aurora Biopharma Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Aurora Biopharma Inc Recent Developments and Future Plans
2.10 Saneron CCEL Therapeutics,Inc
2.10.1 Saneron CCEL Therapeutics,Inc Details
2.10.2 Saneron CCEL Therapeutics,Inc Major Business
2.10.3 Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Product and Solutions
2.10.4 Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Saneron CCEL Therapeutics,Inc Recent Developments and Future Plans
2.11 Kuur Therapeutics
2.11.1 Kuur Therapeutics Details
2.11.2 Kuur Therapeutics Major Business
2.11.3 Kuur Therapeutics Personalized Cell Therapy Product and Solutions
2.11.4 Kuur Therapeutics Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Kuur Therapeutics Recent Developments and Future Plans
2.12 MediGene AG
2.12.1 MediGene AG Details
2.12.2 MediGene AG Major Business
2.12.3 MediGene AG Personalized Cell Therapy Product and Solutions
2.12.4 MediGene AG Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 MediGene AG Recent Developments and Future Plans
2.13 Sangamo Therapeutics
2.13.1 Sangamo Therapeutics Details
2.13.2 Sangamo Therapeutics Major Business
2.13.3 Sangamo Therapeutics Personalized Cell Therapy Product and Solutions
2.13.4 Sangamo Therapeutics Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sangamo Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Personalized Cell Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Personalized Cell Therapy by Company Revenue
3.2.2 Top 3 Personalized Cell Therapy Players Market Share in 2023
3.2.3 Top 6 Personalized Cell Therapy Players Market Share in 2023
3.3 Personalized Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Personalized Cell Therapy Market: Region Footprint
3.3.2 Personalized Cell Therapy Market: Company Product Type Footprint
3.3.3 Personalized Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Personalized Cell Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Personalized Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Personalized Cell Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Personalized Cell Therapy Market Forecast by Application (2025-2030)

6 North America
6.1 North America Personalized Cell Therapy Consumption Value by Type (2019-2030)
6.2 North America Personalized Cell Therapy Consumption Value by Application (2019-2030)
6.3 North America Personalized Cell Therapy Market Size by Country
6.3.1 North America Personalized Cell Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Personalized Cell Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Personalized Cell Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Personalized Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Personalized Cell Therapy Consumption Value by Type (2019-2030)
7.2 Europe Personalized Cell Therapy Consumption Value by Application (2019-2030)
7.3 Europe Personalized Cell Therapy Market Size by Country
7.3.1 Europe Personalized Cell Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.3 France Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Personalized Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Personalized Cell Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Personalized Cell Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Personalized Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Personalized Cell Therapy Consumption Value by Region (2019-2030)
8.3.2 China Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.5 India Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Personalized Cell Therapy Market Size and Forecast (2019-2030)

9 South America
9.1 South America Personalized Cell Therapy Consumption Value by Type (2019-2030)
9.2 South America Personalized Cell Therapy Consumption Value by Application (2019-2030)
9.3 South America Personalized Cell Therapy Market Size by Country
9.3.1 South America Personalized Cell Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Personalized Cell Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Personalized Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Personalized Cell Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Personalized Cell Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Personalized Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Personalized Cell Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Personalized Cell Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Personalized Cell Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Personalized Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Personalized Cell Therapy Market Drivers
11.2 Personalized Cell Therapy Market Restraints
11.3 Personalized Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Personalized Cell Therapy Industry Chain
12.2 Personalized Cell Therapy Upstream Analysis
12.3 Personalized Cell Therapy Midstream Analysis
12.4 Personalized Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Personalized Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Personalized Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Personalized Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Personalized Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis AG Company Information, Head Office, and Major Competitors
Table 6. Novartis AG Major Business
Table 7. Novartis AG Personalized Cell Therapy Product and Solutions
Table 8. Novartis AG Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis AG Recent Developments and Future Plans
Table 10. Vericel Corporation Company Information, Head Office, and Major Competitors
Table 11. Vericel Corporation Major Business
Table 12. Vericel Corporation Personalized Cell Therapy Product and Solutions
Table 13. Vericel Corporation Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Vericel Corporation Recent Developments and Future Plans
Table 15. Bellicum Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Bellicum Pharmaceuticals Major Business
Table 17. Bellicum Pharmaceuticals Personalized Cell Therapy Product and Solutions
Table 18. Bellicum Pharmaceuticals Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bellicum Pharmaceuticals Recent Developments and Future Plans
Table 20. MolMed SpA Company Information, Head Office, and Major Competitors
Table 21. MolMed SpA Major Business
Table 22. MolMed SpA Personalized Cell Therapy Product and Solutions
Table 23. MolMed SpA Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. MolMed SpA Recent Developments and Future Plans
Table 25. Cytori Therapeutics Inc Company Information, Head Office, and Major Competitors
Table 26. Cytori Therapeutics Inc Major Business
Table 27. Cytori Therapeutics Inc Personalized Cell Therapy Product and Solutions
Table 28. Cytori Therapeutics Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Cytori Therapeutics Inc Recent Developments and Future Plans
Table 30. Gilead Sciences, Inc Company Information, Head Office, and Major Competitors
Table 31. Gilead Sciences, Inc Major Business
Table 32. Gilead Sciences, Inc Personalized Cell Therapy Product and Solutions
Table 33. Gilead Sciences, Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Gilead Sciences, Inc Recent Developments and Future Plans
Table 35. Celgene Corporation Company Information, Head Office, and Major Competitors
Table 36. Celgene Corporation Major Business
Table 37. Celgene Corporation Personalized Cell Therapy Product and Solutions
Table 38. Celgene Corporation Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Celgene Corporation Recent Developments and Future Plans
Table 40. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 41. Bluebird Bio Major Business
Table 42. Bluebird Bio Personalized Cell Therapy Product and Solutions
Table 43. Bluebird Bio Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bluebird Bio Recent Developments and Future Plans
Table 45. Aurora Biopharma Inc Company Information, Head Office, and Major Competitors
Table 46. Aurora Biopharma Inc Major Business
Table 47. Aurora Biopharma Inc Personalized Cell Therapy Product and Solutions
Table 48. Aurora Biopharma Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Aurora Biopharma Inc Recent Developments and Future Plans
Table 50. Saneron CCEL Therapeutics,Inc Company Information, Head Office, and Major Competitors
Table 51. Saneron CCEL Therapeutics,Inc Major Business
Table 52. Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Product and Solutions
Table 53. Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Saneron CCEL Therapeutics,Inc Recent Developments and Future Plans
Table 55. Kuur Therapeutics Company Information, Head Office, and Major Competitors
Table 56. Kuur Therapeutics Major Business
Table 57. Kuur Therapeutics Personalized Cell Therapy Product and Solutions
Table 58. Kuur Therapeutics Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Kuur Therapeutics Recent Developments and Future Plans
Table 60. MediGene AG Company Information, Head Office, and Major Competitors
Table 61. MediGene AG Major Business
Table 62. MediGene AG Personalized Cell Therapy Product and Solutions
Table 63. MediGene AG Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. MediGene AG Recent Developments and Future Plans
Table 65. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Sangamo Therapeutics Major Business
Table 67. Sangamo Therapeutics Personalized Cell Therapy Product and Solutions
Table 68. Sangamo Therapeutics Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Sangamo Therapeutics Recent Developments and Future Plans
Table 70. Global Personalized Cell Therapy Revenue (USD Million) by Players (2019-2024)
Table 71. Global Personalized Cell Therapy Revenue Share by Players (2019-2024)
Table 72. Breakdown of Personalized Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Personalized Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Personalized Cell Therapy Players
Table 75. Personalized Cell Therapy Market: Company Product Type Footprint
Table 76. Personalized Cell Therapy Market: Company Product Application Footprint
Table 77. Personalized Cell Therapy New Market Entrants and Barriers to Market Entry
Table 78. Personalized Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Personalized Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Personalized Cell Therapy Consumption Value Share by Type (2019-2024)
Table 81. Global Personalized Cell Therapy Consumption Value Forecast by Type (2025-2030)
Table 82. Global Personalized Cell Therapy Consumption Value by Application (2019-2024)
Table 83. Global Personalized Cell Therapy Consumption Value Forecast by Application (2025-2030)
Table 84. North America Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Personalized Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Personalized Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Personalized Cell Therapy Raw Material
Table 115. Key Suppliers of Personalized Cell Therapy Raw Materials
List of Figures
Figure 1. Personalized Cell Therapy Picture
Figure 2. Global Personalized Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Personalized Cell Therapy Consumption Value Market Share by Type in 2023
Figure 4. Hematopoietic Stem Cell
Figure 5. Skeletal Muscle Stem Cell
Figure 6. Mesenchymal Stem Cells
Figure 7. Lymphocytes
Figure 8. Others
Figure 9. Global Personalized Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Personalized Cell Therapy Consumption Value Market Share by Application in 2023
Figure 11. Cardiovascular Diseases Picture
Figure 12. Neurological Disorders Picture
Figure 13. Inflammatory Diseases Picture
Figure 14. Diabetes Picture
Figure 15. Cancer Picture
Figure 16. Others Picture
Figure 17. Global Personalized Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Personalized Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Personalized Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Personalized Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Personalized Cell Therapy Consumption Value Market Share by Region in 2023
Figure 22. North America Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Personalized Cell Therapy Revenue Share by Players in 2023
Figure 28. Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Personalized Cell Therapy Market Share in 2023
Figure 30. Global Top 6 Players Personalized Cell Therapy Market Share in 2023
Figure 31. Global Personalized Cell Therapy Consumption Value Share by Type (2019-2024)
Figure 32. Global Personalized Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 33. Global Personalized Cell Therapy Consumption Value Share by Application (2019-2024)
Figure 34. Global Personalized Cell Therapy Market Share Forecast by Application (2025-2030)
Figure 35. North America Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. France Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Personalized Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 52. China Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 55. India Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 69. Personalized Cell Therapy Market Drivers
Figure 70. Personalized Cell Therapy Market Restraints
Figure 71. Personalized Cell Therapy Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Personalized Cell Therapy in 2023
Figure 74. Manufacturing Process Analysis of Personalized Cell Therapy
Figure 75. Personalized Cell Therapy Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics,Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Personalized Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Personalized Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 108

Published Date: 12 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Personalized Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease
The Global Info Research report includes an overview of the development of the Personalized Cell Therapy industry chain, the market status of Cardiovascular Diseases (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell), Neurological Disorders (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Personalized Cell Therapy.

Regionally, the report analyzes the Personalized Cell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Personalized Cell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Personalized Cell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Personalized Cell Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hematopoietic Stem Cell, Skeletal Muscle Stem Cell).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Personalized Cell Therapy market.

Regional Analysis: The report involves examining the Personalized Cell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Personalized Cell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Personalized Cell Therapy:
Company Analysis: Report covers individual Personalized Cell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Personalized Cell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular Diseases, Neurological Disorders).

Technology Analysis: Report covers specific technologies relevant to Personalized Cell Therapy. It assesses the current state, advancements, and potential future developments in Personalized Cell Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Personalized Cell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Personalized Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
By Cell Type
Hematopoietic Stem Cell
Skeletal Muscle Stem Cell
Mesenchymal Stem Cells
Lymphocytes
Others
By Technique
Platelet Transfusions
Bone Marrow Transplantation
Packed Red Cell Transfusions
Organ Transplantation

Market segment by Application
Cardiovascular Diseases
Neurological Disorders
Inflammatory Diseases
Diabetes
Cancer
Others

Market segment by players, this report covers
Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics,Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Cell Therapy, with revenue, gross margin and global market share of Personalized Cell Therapy from 2019 to 2024.
Chapter 3, the Personalized Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Personalized Cell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Cell Therapy.
Chapter 13, to describe Personalized Cell Therapy research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Personalized Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Cell Therapy by Type
1.3.1 Overview: Global Personalized Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Personalized Cell Therapy Consumption Value Market Share by Type in 2023
1.3.3 Hematopoietic Stem Cell
1.3.4 Skeletal Muscle Stem Cell
1.3.5 Mesenchymal Stem Cells
1.3.6 Lymphocytes
1.3.7 Others
1.4 Global Personalized Cell Therapy Market by Application
1.4.1 Overview: Global Personalized Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cardiovascular Diseases
1.4.3 Neurological Disorders
1.4.4 Inflammatory Diseases
1.4.5 Diabetes
1.4.6 Cancer
1.4.7 Others
1.5 Global Personalized Cell Therapy Market Size & Forecast
1.6 Global Personalized Cell Therapy Market Size and Forecast by Region
1.6.1 Global Personalized Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Personalized Cell Therapy Market Size by Region, (2019-2030)
1.6.3 North America Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Personalized Cell Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Personalized Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Personalized Cell Therapy Product and Solutions
2.1.4 Novartis AG Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Vericel Corporation
2.2.1 Vericel Corporation Details
2.2.2 Vericel Corporation Major Business
2.2.3 Vericel Corporation Personalized Cell Therapy Product and Solutions
2.2.4 Vericel Corporation Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Vericel Corporation Recent Developments and Future Plans
2.3 Bellicum Pharmaceuticals
2.3.1 Bellicum Pharmaceuticals Details
2.3.2 Bellicum Pharmaceuticals Major Business
2.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Product and Solutions
2.3.4 Bellicum Pharmaceuticals Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bellicum Pharmaceuticals Recent Developments and Future Plans
2.4 MolMed SpA
2.4.1 MolMed SpA Details
2.4.2 MolMed SpA Major Business
2.4.3 MolMed SpA Personalized Cell Therapy Product and Solutions
2.4.4 MolMed SpA Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MolMed SpA Recent Developments and Future Plans
2.5 Cytori Therapeutics Inc
2.5.1 Cytori Therapeutics Inc Details
2.5.2 Cytori Therapeutics Inc Major Business
2.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Product and Solutions
2.5.4 Cytori Therapeutics Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cytori Therapeutics Inc Recent Developments and Future Plans
2.6 Gilead Sciences, Inc
2.6.1 Gilead Sciences, Inc Details
2.6.2 Gilead Sciences, Inc Major Business
2.6.3 Gilead Sciences, Inc Personalized Cell Therapy Product and Solutions
2.6.4 Gilead Sciences, Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business
2.7.3 Celgene Corporation Personalized Cell Therapy Product and Solutions
2.7.4 Celgene Corporation Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Celgene Corporation Recent Developments and Future Plans
2.8 Bluebird Bio
2.8.1 Bluebird Bio Details
2.8.2 Bluebird Bio Major Business
2.8.3 Bluebird Bio Personalized Cell Therapy Product and Solutions
2.8.4 Bluebird Bio Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bluebird Bio Recent Developments and Future Plans
2.9 Aurora Biopharma Inc
2.9.1 Aurora Biopharma Inc Details
2.9.2 Aurora Biopharma Inc Major Business
2.9.3 Aurora Biopharma Inc Personalized Cell Therapy Product and Solutions
2.9.4 Aurora Biopharma Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Aurora Biopharma Inc Recent Developments and Future Plans
2.10 Saneron CCEL Therapeutics,Inc
2.10.1 Saneron CCEL Therapeutics,Inc Details
2.10.2 Saneron CCEL Therapeutics,Inc Major Business
2.10.3 Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Product and Solutions
2.10.4 Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Saneron CCEL Therapeutics,Inc Recent Developments and Future Plans
2.11 Kuur Therapeutics
2.11.1 Kuur Therapeutics Details
2.11.2 Kuur Therapeutics Major Business
2.11.3 Kuur Therapeutics Personalized Cell Therapy Product and Solutions
2.11.4 Kuur Therapeutics Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Kuur Therapeutics Recent Developments and Future Plans
2.12 MediGene AG
2.12.1 MediGene AG Details
2.12.2 MediGene AG Major Business
2.12.3 MediGene AG Personalized Cell Therapy Product and Solutions
2.12.4 MediGene AG Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 MediGene AG Recent Developments and Future Plans
2.13 Sangamo Therapeutics
2.13.1 Sangamo Therapeutics Details
2.13.2 Sangamo Therapeutics Major Business
2.13.3 Sangamo Therapeutics Personalized Cell Therapy Product and Solutions
2.13.4 Sangamo Therapeutics Personalized Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sangamo Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Personalized Cell Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Personalized Cell Therapy by Company Revenue
3.2.2 Top 3 Personalized Cell Therapy Players Market Share in 2023
3.2.3 Top 6 Personalized Cell Therapy Players Market Share in 2023
3.3 Personalized Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Personalized Cell Therapy Market: Region Footprint
3.3.2 Personalized Cell Therapy Market: Company Product Type Footprint
3.3.3 Personalized Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Personalized Cell Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Personalized Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Personalized Cell Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Personalized Cell Therapy Market Forecast by Application (2025-2030)

6 North America
6.1 North America Personalized Cell Therapy Consumption Value by Type (2019-2030)
6.2 North America Personalized Cell Therapy Consumption Value by Application (2019-2030)
6.3 North America Personalized Cell Therapy Market Size by Country
6.3.1 North America Personalized Cell Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Personalized Cell Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Personalized Cell Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Personalized Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Personalized Cell Therapy Consumption Value by Type (2019-2030)
7.2 Europe Personalized Cell Therapy Consumption Value by Application (2019-2030)
7.3 Europe Personalized Cell Therapy Market Size by Country
7.3.1 Europe Personalized Cell Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.3 France Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Personalized Cell Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Personalized Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Personalized Cell Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Personalized Cell Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Personalized Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Personalized Cell Therapy Consumption Value by Region (2019-2030)
8.3.2 China Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.5 India Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Personalized Cell Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Personalized Cell Therapy Market Size and Forecast (2019-2030)

9 South America
9.1 South America Personalized Cell Therapy Consumption Value by Type (2019-2030)
9.2 South America Personalized Cell Therapy Consumption Value by Application (2019-2030)
9.3 South America Personalized Cell Therapy Market Size by Country
9.3.1 South America Personalized Cell Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Personalized Cell Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Personalized Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Personalized Cell Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Personalized Cell Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Personalized Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Personalized Cell Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Personalized Cell Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Personalized Cell Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Personalized Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Personalized Cell Therapy Market Drivers
11.2 Personalized Cell Therapy Market Restraints
11.3 Personalized Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Personalized Cell Therapy Industry Chain
12.2 Personalized Cell Therapy Upstream Analysis
12.3 Personalized Cell Therapy Midstream Analysis
12.4 Personalized Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Personalized Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Personalized Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Personalized Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Personalized Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis AG Company Information, Head Office, and Major Competitors
Table 6. Novartis AG Major Business
Table 7. Novartis AG Personalized Cell Therapy Product and Solutions
Table 8. Novartis AG Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis AG Recent Developments and Future Plans
Table 10. Vericel Corporation Company Information, Head Office, and Major Competitors
Table 11. Vericel Corporation Major Business
Table 12. Vericel Corporation Personalized Cell Therapy Product and Solutions
Table 13. Vericel Corporation Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Vericel Corporation Recent Developments and Future Plans
Table 15. Bellicum Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Bellicum Pharmaceuticals Major Business
Table 17. Bellicum Pharmaceuticals Personalized Cell Therapy Product and Solutions
Table 18. Bellicum Pharmaceuticals Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bellicum Pharmaceuticals Recent Developments and Future Plans
Table 20. MolMed SpA Company Information, Head Office, and Major Competitors
Table 21. MolMed SpA Major Business
Table 22. MolMed SpA Personalized Cell Therapy Product and Solutions
Table 23. MolMed SpA Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. MolMed SpA Recent Developments and Future Plans
Table 25. Cytori Therapeutics Inc Company Information, Head Office, and Major Competitors
Table 26. Cytori Therapeutics Inc Major Business
Table 27. Cytori Therapeutics Inc Personalized Cell Therapy Product and Solutions
Table 28. Cytori Therapeutics Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Cytori Therapeutics Inc Recent Developments and Future Plans
Table 30. Gilead Sciences, Inc Company Information, Head Office, and Major Competitors
Table 31. Gilead Sciences, Inc Major Business
Table 32. Gilead Sciences, Inc Personalized Cell Therapy Product and Solutions
Table 33. Gilead Sciences, Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Gilead Sciences, Inc Recent Developments and Future Plans
Table 35. Celgene Corporation Company Information, Head Office, and Major Competitors
Table 36. Celgene Corporation Major Business
Table 37. Celgene Corporation Personalized Cell Therapy Product and Solutions
Table 38. Celgene Corporation Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Celgene Corporation Recent Developments and Future Plans
Table 40. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 41. Bluebird Bio Major Business
Table 42. Bluebird Bio Personalized Cell Therapy Product and Solutions
Table 43. Bluebird Bio Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bluebird Bio Recent Developments and Future Plans
Table 45. Aurora Biopharma Inc Company Information, Head Office, and Major Competitors
Table 46. Aurora Biopharma Inc Major Business
Table 47. Aurora Biopharma Inc Personalized Cell Therapy Product and Solutions
Table 48. Aurora Biopharma Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Aurora Biopharma Inc Recent Developments and Future Plans
Table 50. Saneron CCEL Therapeutics,Inc Company Information, Head Office, and Major Competitors
Table 51. Saneron CCEL Therapeutics,Inc Major Business
Table 52. Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Product and Solutions
Table 53. Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Saneron CCEL Therapeutics,Inc Recent Developments and Future Plans
Table 55. Kuur Therapeutics Company Information, Head Office, and Major Competitors
Table 56. Kuur Therapeutics Major Business
Table 57. Kuur Therapeutics Personalized Cell Therapy Product and Solutions
Table 58. Kuur Therapeutics Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Kuur Therapeutics Recent Developments and Future Plans
Table 60. MediGene AG Company Information, Head Office, and Major Competitors
Table 61. MediGene AG Major Business
Table 62. MediGene AG Personalized Cell Therapy Product and Solutions
Table 63. MediGene AG Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. MediGene AG Recent Developments and Future Plans
Table 65. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Sangamo Therapeutics Major Business
Table 67. Sangamo Therapeutics Personalized Cell Therapy Product and Solutions
Table 68. Sangamo Therapeutics Personalized Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Sangamo Therapeutics Recent Developments and Future Plans
Table 70. Global Personalized Cell Therapy Revenue (USD Million) by Players (2019-2024)
Table 71. Global Personalized Cell Therapy Revenue Share by Players (2019-2024)
Table 72. Breakdown of Personalized Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Personalized Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Personalized Cell Therapy Players
Table 75. Personalized Cell Therapy Market: Company Product Type Footprint
Table 76. Personalized Cell Therapy Market: Company Product Application Footprint
Table 77. Personalized Cell Therapy New Market Entrants and Barriers to Market Entry
Table 78. Personalized Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Personalized Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Personalized Cell Therapy Consumption Value Share by Type (2019-2024)
Table 81. Global Personalized Cell Therapy Consumption Value Forecast by Type (2025-2030)
Table 82. Global Personalized Cell Therapy Consumption Value by Application (2019-2024)
Table 83. Global Personalized Cell Therapy Consumption Value Forecast by Application (2025-2030)
Table 84. North America Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Personalized Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Personalized Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Personalized Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Personalized Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Personalized Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Personalized Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Personalized Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Personalized Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Personalized Cell Therapy Raw Material
Table 115. Key Suppliers of Personalized Cell Therapy Raw Materials
List of Figures
Figure 1. Personalized Cell Therapy Picture
Figure 2. Global Personalized Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Personalized Cell Therapy Consumption Value Market Share by Type in 2023
Figure 4. Hematopoietic Stem Cell
Figure 5. Skeletal Muscle Stem Cell
Figure 6. Mesenchymal Stem Cells
Figure 7. Lymphocytes
Figure 8. Others
Figure 9. Global Personalized Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Personalized Cell Therapy Consumption Value Market Share by Application in 2023
Figure 11. Cardiovascular Diseases Picture
Figure 12. Neurological Disorders Picture
Figure 13. Inflammatory Diseases Picture
Figure 14. Diabetes Picture
Figure 15. Cancer Picture
Figure 16. Others Picture
Figure 17. Global Personalized Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Personalized Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Personalized Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Personalized Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Personalized Cell Therapy Consumption Value Market Share by Region in 2023
Figure 22. North America Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Personalized Cell Therapy Revenue Share by Players in 2023
Figure 28. Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Personalized Cell Therapy Market Share in 2023
Figure 30. Global Top 6 Players Personalized Cell Therapy Market Share in 2023
Figure 31. Global Personalized Cell Therapy Consumption Value Share by Type (2019-2024)
Figure 32. Global Personalized Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 33. Global Personalized Cell Therapy Consumption Value Share by Application (2019-2024)
Figure 34. Global Personalized Cell Therapy Market Share Forecast by Application (2025-2030)
Figure 35. North America Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. France Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Personalized Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 52. China Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 55. India Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Personalized Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Personalized Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Personalized Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Personalized Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 69. Personalized Cell Therapy Market Drivers
Figure 70. Personalized Cell Therapy Market Restraints
Figure 71. Personalized Cell Therapy Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Personalized Cell Therapy in 2023
Figure 74. Manufacturing Process Analysis of Personalized Cell Therapy
Figure 75. Personalized Cell Therapy Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics,Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now